Table: Fuso Pharmaceutical -2022/23 parent results

Fuso Pharmaceutical Industries

10/05/2023 05:40

May 10 (Reuters)- 
          Fuso Pharmaceutical Industries Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2023    Mar 31, 2022   Mar 31, 2024     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           51.02           49.63          53.30        26.50    
               (+2.8 pct)      (+0.8 pct)     (+4.5 pct)    (+4.4 pct) 
  Operating        2.21            1.92           2.00         1.00    
               (+14.7 pct)     (-18.2 pct)    (-9.4 pct)   (-22.2 pct) 
  Recurring        2.22            2.00           2.00         1.00    
               (+11.0 pct)     (-10.4 pct)    (-9.7 pct)   (-28.5 pct) 
  Net              1.61            1.48           1.30       700 mln   
               (+8.3 pct)      (-7.7 pct)     (-19.0 pct)  (-31.3 pct) 
  EPS          183.07 yen      169.09 yen     148.21 yen    79.81 yen  
  Ann Div       70.00 yen       60.00 yen      70.00 yen               
  -Q2 Div       30.00 yen       30.00 yen      35.00 yen               
  -Q4 Div       40.00 yen       30.00 yen      35.00 yen               
  
  NOTE - Fuso Pharmaceutical Industries Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4538.T